Damora Therapeutics is trading 5.18% lower at $17.77, with no company-specific announcement explaining the October 16, 2026 move surfaced in the available search.
- The company’s investor-relations page lists an October 2 release about employee inducement grants.
- Market context does not clearly explain the decline: major indexes are mixed and healthcare is higher, while a separate October 16 report says healthcare stocks fell 0.8% that day.